Healthcare

Europe faces a growing chronic wound crisis - time to act is now

GOTHENBURG, Sweden, March 31, 2026, 13:09 GMT-04

Mölnlycke-MedTech

Read full article →

Europe faces a growing chronic wound crisis - time to act is now

GOTHENBURG, Sweden, March 31, 2026, 12:18 GMT-04

MOLNLYCKE

Read full article →

Grand View Research Launches Advanced U.S. Healthcare Facility Mapping & Intelligence Platform to Enable Data-Driven Decision Making Across the Healthcare Ecosystem

SAN FRANCISCO, March 31, 2026, 12:08 GMT-04

GVR-Healthcare

Read full article →

Cell Therapy Market Size to Surpass USD 17.15 Billion by 2032, Driven by Chronic Disease Treatment and CAR-T Therapy Growth, Says New MMR Analysis

PUNE, India, March 31, 2026, 11:40 GMT-04

MMR-Cell-Therapy

Read full article →

Global Medical Nutrition Market to Reach USD 31.1 Billion by 2035, Driven by Preventive Healthcare Across North America, Europe & Asia-Pacific - Key Players Nestlé, Abbott, Danone & DSM Lead Innovation

NEWARK, Del., March 31, 2026, 10:19 GMT-04

FMI-med-nutri-outlook

Read full article →

Autoinjectors Market worth $300.46 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., March 31, 2026, 10:15 GMT-04

MarketsandMarkets

Read full article →

i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD

BLOOMINGTON, Minn., March 31, 2026, 10:14 GMT-04

i-LUMEN-SCIENTIFIC

Read full article →

HPS/PayMedix adds Marshfield Clinic Health System Hospitals and Providers to Network in WI and MI

MILWAUKEE, March 31, 2026, 10:00 GMT-04

HPS-PAYMEDIX-MCHS

Read full article →

Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2

BEIJING and BRIDGEWATER, N.J., March 31, 2026, 09:47 GMT-04

GanLee-Pharma

Read full article →

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

TAMPA, Fla., March 31, 2026, 03:56 GMT-04

Concept-Medical

Read full article →

Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program

GOTHENBURG, Sweden, March 31, 2026, 03:16 GMT-04

CERENO-CS1-PAH-safety

Read full article →

Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M

HERZLIYA, Israel and CALGARY, AB, March 31, 2026, 03:04 GMT-04

Innocan-2025-Results

Read full article →

DNV SELECTED TO CERTIFY CLASS D DEVICES FOR LEADING U.S. MANUFACTURER UNDER EU IVDR

OSLO, Norway, March 31, 2026, 03:00 GMT-04

DNV-EU-IVDR

Read full article →

Tigermed Announces 2025 Annual Results

HANGZHOU, China, March 30, 2026, 09:05 GMT-04

Tigermed-25-Reults

Read full article →

CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"

SEOUL, South Korea and BANGKOK, March 30, 2026, 08:00 GMT-04

CGBIO-Thailand

Read full article →

Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026

SANTA CRUZ, Calif., March 30, 2026, 08:00 GMT-04

Emboline-PROTECT-H2H

Read full article →

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants

CORAL SPRINGS, Fla., March 30, 2026, 07:30 GMT-04

Neurolief

Read full article →

EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

STOCKHOLM, March 30, 2026, 02:23 GMT-04

SOBI-EMA

Read full article →

Singclean Global Aesthetic Master Symposium Makes Landmark Debut in Monaco

MONACO, March 30, 2026, 23:30 GMT-04

HangzhouSingclean

Read full article →

Smartee Advances "Mandibular Repositioning" Solutions in the UK with Specialized Clinical Conference in London

LONDON, March 29, 2026, 14:03 GMT-04

Smartee-Denti-Techn

Read full article →